Correction to: Development of a novel TLR8 agonist for cancer immunotherapy
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2021-05-01
|
Series: | Molecular Biomedicine |
Online Access: | https://doi.org/10.1186/s43556-021-00042-3 |